Search research articles
Contact Us
Filters
Showing results (111-120 of 137) with videos related to
Page
of 14
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 6, 2001
5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization
N Froger, A M Gardier, R Moratalla, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 1999
Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC)
C Boni, L Savoldi, G Bisagni, et al.
American Journal of Clinical Oncology
|
August 26, 1998
High-dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research
F Di Costanzo, S Gasperoni, P Malacarne, et al.
Breast (Edinburgh, Scotland)
|
January 21, 2004
Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifen
M Freue, M Kjaer, C Boni, et al.
British Journal of Cancer
|
April 4, 2013
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin
M Tiseo, P Bordi, B Bortesi, et al.
Chemotherapy
|
May 21, 2011
Optimizing clinical care in patients with advanced soft tissue sarcoma: a phase II study of a new schedule of high-dose continuous infusion ifosfamide and doxorubicin combination
T De Pas, G Rosati, G Spitaleri, et al.
Gastroenterology
|
December 2, 1999
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection
M K Maini, C Boni, G S Ogg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2005
Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy
S I Helle, W Mietlowski, J P Guastalla, et al.
The Journal of Experimental Medicine
|
April 19, 2000
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection
M K Maini, C Boni, C K Lee, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 21, 2002
Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study
M Colozza, G Bisagni, A M Mosconi, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 137) with videos related to
Sort By:
Page
of 14
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 6, 2001
5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization
N Froger, A M Gardier, R Moratalla, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 1999
Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC)
C Boni, L Savoldi, G Bisagni, et al.
American Journal of Clinical Oncology
|
August 26, 1998
High-dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research
F Di Costanzo, S Gasperoni, P Malacarne, et al.
Breast (Edinburgh, Scotland)
|
January 21, 2004
Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifen
M Freue, M Kjaer, C Boni, et al.
British Journal of Cancer
|
April 4, 2013
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin
M Tiseo, P Bordi, B Bortesi, et al.
Chemotherapy
|
May 21, 2011
Optimizing clinical care in patients with advanced soft tissue sarcoma: a phase II study of a new schedule of high-dose continuous infusion ifosfamide and doxorubicin combination
T De Pas, G Rosati, G Spitaleri, et al.
Gastroenterology
|
December 2, 1999
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection
M K Maini, C Boni, G S Ogg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2005
Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy
S I Helle, W Mietlowski, J P Guastalla, et al.
The Journal of Experimental Medicine
|
April 19, 2000
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection
M K Maini, C Boni, C K Lee, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 21, 2002
Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study
M Colozza, G Bisagni, A M Mosconi, et al.
Page
of 14